Adeshwar Meditex Limited (BOM:543309)
India · Delayed Price · Currency is INR 16.35
+1.35 (9.00%)
At close: Sep 11, 2026
Adeshwar Meditex Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 561.04 | 837.13 | 798.5 | 823.57 | 647.55 |
Other Revenue | -0 | - | - | - | - |
| 561.04 | 837.13 | 798.5 | 823.57 | 647.55 | |
Revenue Growth | -32.98% | 4.84% | -3.04% | 27.18% | -1.84% |
Cost of Revenue | 472.99 | 746.14 | 700.38 | 700.77 | 550.74 |
Gross Profit | 88.05 | 90.99 | 98.12 | 122.8 | 96.82 |
Selling, General & Admin | 30.11 | 21.96 | 17.65 | 21.06 | 21.52 |
Other Operating Expenses | 29.27 | 23.68 | 27.16 | 47.25 | 39.45 |
Operating Expenses | 63.67 | 50.63 | 50.82 | 73.63 | 64.8 |
Operating Income | 24.38 | 40.36 | 47.3 | 49.17 | 32.02 |
Interest Expense | -5.67 | -12.21 | -17.21 | -19.53 | -19.39 |
Currency Exchange Gain (Loss) | 0.07 | 0.28 | -0.19 | 0.76 | 0.41 |
Other Non Operating Income (Expenses) | -0.46 | -1.72 | -2.05 | -1.36 | -1.13 |
EBT Excluding Unusual Items | 18.32 | 26.7 | 27.85 | 29.04 | 11.91 |
Gain (Loss) on Sale of Investments | - | 1.24 | - | - | - |
Pretax Income | 18.32 | 27.93 | 27.85 | 29.04 | 11.91 |
Income Tax Expense | 5.67 | 7.28 | 7.77 | 8.3 | 3.98 |
Net Income | 12.65 | 20.66 | 20.08 | 20.74 | 7.93 |
Net Income to Common | 12.65 | 20.66 | 20.08 | 20.74 | 7.93 |
Net Income Growth | -38.77% | 2.87% | -3.19% | 161.58% | -52.73% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 |
Shares Change | - | - | - | - | 37.03% |
EPS (Basic) | 0.88 | 1.43 | 1.39 | 1.44 | 0.55 |
EPS (Diluted) | 0.88 | 1.43 | 1.39 | 1.44 | 0.55 |
EPS Growth | -38.70% | 2.88% | -3.29% | 161.58% | -65.44% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 48.86 | 36.51 | 34.09 | 57.67 | -36.07 |
Free Cash Flow Per Share | 3.39 | 2.53 | 2.36 | 4.00 | -2.50 |
Gross Margin | 15.69% | 10.87% | 12.29% | 14.91% | 14.95% |
Operating Margin | 4.35% | 4.82% | 5.92% | 5.97% | 4.95% |
Profit Margin | 2.25% | 2.47% | 2.51% | 2.52% | 1.22% |
Free Cash Flow Margin | 8.71% | 4.36% | 4.27% | 7.00% | -5.57% |
EBITDA | 28.66 | 45.35 | 53.31 | 54.48 | 35.84 |
EBITDA Margin | 5.11% | 5.42% | 6.68% | 6.62% | 5.54% |
D&A For EBITDA | 4.28 | 4.99 | 6.01 | 5.31 | 3.82 |
EBIT | 24.38 | 40.36 | 47.3 | 49.17 | 32.02 |
EBIT Margin | 4.35% | 4.82% | 5.92% | 5.97% | 4.95% |
Effective Tax Rate | 30.95% | 26.05% | 27.91% | 28.59% | 33.43% |
Revenue as Reported | 562.08 | 839.72 | 799.83 | 826.63 | 649.84 |